Alnylam Pharmaceuticals Inc – Lobbying Governance & Transparency

Sign up to access all our data and the evidence and analysis underlying our overall scores. Once you've created an account, we'll get in touch with further details:

Lobbying Governance

Overall Assessment	Analysis	Score
None	Alnylam Pharmaceuticals outlines that “our voice, and the voice of our patients, is heard regarding key topics including patient access, drug pricing, and health equity, among others” and that “Alnylam’s Political Action Committee (PAC) contributes to candidates for federal office in both major parties and complies with all Federal Election Commission regulations and rules regarding contributions and disclosure.” However, the company does not disclose any internal governance process for its lobbying activities: there is no information on who oversees lobbying, how lobbying engagements are monitored or managed, or any mechanisms to align its direct or indirect lobbying with company policy or any climate objectives. View Sources	E

Overall Assessment

Analysis

Score

None

Alnylam Pharmaceuticals outlines that “our voice, and the voice of our patients, is heard regarding key topics including patient access, drug pricing, and health equity, among others” and that “Alnylam’s Political Action Committee (PAC) contributes to candidates for federal office in both major parties and complies with all Federal Election Commission regulations and rules regarding contributions and disclosure.” However, the company does not disclose any internal governance process for its lobbying activities: there is no information on who oversees lobbying, how lobbying engagements are monitored or managed, or any mechanisms to align its direct or indirect lobbying with company policy or any climate objectives.

View Sources

Lobbying Transparency

Overall Assessment	Analysis	Score
None	No evidence found	E